1. Wong, SH, Lui, RN, Sung, JJ (2020) Covid-19 and the digestive system. J ournal of Gastroenterology and Hepatology 35(5): 744–748.
Google Scholar | Crossref | Medline2. Bozkurt, HS, Quigley, EM (2020) The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. International Journal of Immunopathology and Pharmacology 34: 2058738420961304.
Google Scholar | SAGE Journals | ISI3. Republic Of Turkey Ministry Of Health (2020) COVID-19 (SARS-CoV-2 infection) guide. Turkey: General Directorate of Public Health, Turkish Ministry of Health. Available at: https://hsgm.saglik.gov.tr/depo/birimler/goc_sagligi/covid19/rehber/COVID-19_Rehberi20200414_eng_v4_002_14.05.2020.pdf.
Google Scholar4. Bozkurt, HS, Kara, B (2020) A new treatment for ulcerative colitis: intracolonic Bifidobacterium and xyloglucan application. European Journal of Inflammation 158(3): S57.
Google Scholar5. Hazan, S, Stollman, N, Bozkurt, H (2021) The missing microbes: bifidobacterium and faecalibacterium depletion and loss of microbiome diversity as potential susceptibility markers for SARS-CoV-2 infection and severity. British Medical Journal 21262832.
Google Scholar6. Lu, HZ (2020) Drug treatment options for the 2019-new coronavirus (2019-nCoV). BioScience Trends 14(1): 69–71.
Google Scholar | Crossref | Medline7. Rozga, M, Cheng, FW, Handu, D (2020) Effects of probiotics in conditions or infections similar to COVID-19 on health outcomes: an evidence analysis center scoping review. Journal of the Academy Nutrition and Dietetics 121(9): 1841–1854.
Google Scholar | Crossref | Medline8. Mahooti, M, Miri, SM, Abdolalipour, E, et al. (2020) The immunomodulatory effects of probiotics on respiratory viral infections: a hint for COVID-19 treatment? Microbial Pathogenesis 148: 104452.
Google Scholar | Crossref | Medline9. Sundararaman, A, Ray, M, Ravindra, PV, et al. (2020) Role of probiotics to combat viral infections with emphasis on COVID-19. Applied Microbiology and Biotechnology 104: 8089–8104.
Google Scholar | Crossref | Medline10. Fung, S, Liu, DX (2019) The ER stress sensor IRE1 and MAP kinase ERK modulate autophagy induction in cells infected with coronavirus infectious bronchitis virus. Virology 533: 34–44.
Google Scholar | Crossref | Medline11. Kong, EY, Cheng, SH, Yu, KN (2018) Induction of autophagy and interleukin 6 secretion in bystander cells: metabolic cooperation for radiation-induced rescue effect? Journal of Radiation Research 59(2): 129–140.
Google Scholar | Crossref | Medline12. Hou, W, Jin, YH, Kang, HS, Kim, BS (2014) Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. Journal of Virology 88(15): 8479–8489.
Google Scholar | Crossref | Medline13. Zhang, Y, Li, J, Zhan, Y, et al. (2004) Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infection and Immunity 72: 4410–4415.
Google Scholar | Crossref | Medline | ISI14. Zhou, F, Yu, T, Du, R, et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan. Lancet 395: 1054–1062.
Google Scholar | Crossref | Medline15. Xu, Z, Shi, L, Wang, Y, et al. (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine 8: 420–422.
Google Scholar | Crossref | Medline16. Grifoni, E, Valoriani, A, Cei, F, et al. (2020) Interleukin-6 as prognosticator in patients with COVID-19. The Journal of Infection 81(3): 452–482.
Google Scholar | Crossref | Medline17. Rosas, IO, Bräu, N, Waters, M, et al. (2021) Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. The New England Journal of Medicine 384: 1503–1516.
Google Scholar | Crossref | Medline18. Cavalli, G, Dagna, L (2021). The right place for IL-1 inhibition in COVID-19. The Lancet Respiratory Medicine 9: 223–224.
Google Scholar | Crossref | Medline19. Li, Q, Cheng, F, Xu, Q, et al. (2021) The role of probiotics in coronavirus disease-19 infection in Wuhan: A retrospective study of 311 severe patients. International Immunopharmacology 95: 107531.
Google Scholar | Crossref | Medline20. Santacroce, L, Inchingolo, F, Topi, S, et al. (2021) Potential beneficial role of probiotics on the outcome of COVID-19 patients: an evolving perspective. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15(1): 295–301.
Google Scholar | Crossref | Medline21. Jungersen, M, Wind, A, Johansen, E, et al. (2014). The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12®. Microorganisms; 2(2): 92–110.
Google Scholar | Crossref | Medline22. Bozkurt, K, Denktas, C, Ozdemir, O, et al. (2019) Charge transport in bifidobacterium animalis subsp.lactis BB-12 under various atmospheres. Open Journal of Applied Sciences 9: 506–514.
Google Scholar | Crossref23. Larsen, C, Nielsen, S, Kæstel, P, et al. (2006) Dose–response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. European Journal of Clinical Nutrition 60: 1284–1293.
Google Scholar | Crossref | Medline24. Baindara, P, Chakraborty, R, Holliday, ZM, et al. (2021) Oral probiotics in coronavirus disease 2019: connecting the gut–lung axis to viral pathogenesis, inflammation, secondary infection and clinical trials. New Microbes and New Infections 40: 100837
Google Scholar | Crossref | Medline